Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy
Javier S. Cabrera‐Perez, Vincent J. Carey, Oreofe O. Odejide, Sonal Singh, Thomas S. Kupper, Shiv Pillai, Scott T. Weiss, Ayobami Akenroye
Topics & Concepts
DupilumabMechanism (biology)EpidemiologyLymphomaTranscriptomeMedicineImmunologyBiologyInternal medicineGeneGeneticsGene expressionPhilosophyEpistemologyAsthmaCutaneous lymphoproliferative disorders researchLymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment